Oramed Pharmaceuticals (ORMP) Invested Capital (2011 - 2024)
Oramed Pharmaceuticals' (ORMP) quarterly Invested Capital came in at $32.0 million in Q1 2024, down 37.2% on a QoQ basis from $51.0 million in Q4 2023.
Oramed Pharmaceuticals (ORMP) Invested Capital (2011 - 2024) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 11 years of Invested Capital data on file, last reported at $32.0 million in Q1 2024.
- Quarterly Invested Capital changed N/A year-over-year to $32.0 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $32.0 million (down 74.65% YoY) and the FY2023 annual result came in at $51.0 million, changed N/A from the prior year.
- Invested Capital retreated to $32.0 million in Q1 2024, from $51.0 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $75.4 million in Q3 2023 to a low of $43000.0 in Q1 2020.
- A 4-year average of $17.6 million and a median of $90000.0 in 2020 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2020 — Invested Capital decreased 21.82% — and 2021, when it surged 102.33%.
- Tracing ORMP's Invested Capital over 4 years: stood at $93000.0 in 2020, then sank by 37.63% to $58000.0 in 2021, then surged by 87853.45% to $51.0 million in 2023, then sank by 37.2% to $32.0 million in 2024.
- The last three Invested Capital figures came in at $32.0 million (Q1 2024), $51.0 million (Q4 2023), and $75.4 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 32.03 Mn |
| Dec 31, 2023 | 51.01 Mn |
| Sep 30, 2023 | 75.36 Mn |
| May 31, 2021 | 58,000.00 |
| Feb 28, 2021 | 87,000.00 |
| Nov 30, 2020 | 93,000.00 |
| Aug 31, 2020 | 90,000.00 |
| May 31, 2020 | 50,000.00 |
| Feb 29, 2020 | 43,000.00 |
| Nov 30, 2019 | 96,000.00 |
| Aug 31, 2019 | 64,000.00 |
| May 31, 2019 | 39,000.00 |
| Feb 28, 2019 | 55,000.00 |
| Nov 30, 2018 | 51,000.00 |
| Aug 31, 2018 | 46,000.00 |
| May 31, 2018 | 45,000.00 |
| Feb 28, 2018 | 113,000.00 |
| Nov 30, 2017 | 76,000.00 |
| May 31, 2017 | 61,000.00 |
| Feb 28, 2017 | 60,000.00 |